Clinical trial
Selution DeNovo - A Prospective Randomized, Multi-centre, International, Open Label, Clinical Trial Comparing the Selution DEB Strategy Versus DES Strategy.
NCT04859985 is registered in ClinicalTrials.gov with M.A. Med Alliance S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Selution DeNovo - A Prospective Randomized, Multi-centre, International, Open Label, Clinical Trial Comparing the Selution DEB Strategy Versus DES Strategy.
- Lead sponsor
- M.A. Med Alliance S.A.
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- May 15, 2021
- Completion date
- October 31, 2030
- Enrollment
- 3,326 (actual)
- Sites
- 62
Conditions
As the registry lists them; a condition with its own page is linked.